Posted On: 01/17/2015 12:53:54 PM
Post# of 30066
The Concussion Summit in a week will probably be adding more fuel to our new Diagnostic Company's fire. Dr. Stern has been working on LymPro for concussions for a year now. I suspect he'll be announcing that we'll be doing validation studies soon and be ready for commercialization in 2H of 2015!! I wouldn't be surprised if we acquire another asset to diagnose concussions, as well.
The Diagnostic Company is going to be loaded for bear! (MS, Alzheimers, TBI) Maybe Nuropro will even get into the act. It will be very interesting to see how AMBS plans on "monetizing" LymPro and the Diagnostic Entity to increase shareholder value.
That won't be very far off.
The Diagnostic Company is going to be loaded for bear! (MS, Alzheimers, TBI) Maybe Nuropro will even get into the act. It will be very interesting to see how AMBS plans on "monetizing" LymPro and the Diagnostic Entity to increase shareholder value.
That won't be very far off.
(0)
(0)
